While Gal-3 expression in CRC tissues does not strongly correlate with clinical pathological parameters, it shows a positive association with levels of serum IL-17 and IL-23, suggesting a link between Gal-3 and tumor-related inflammation [328]. The gene discussed is LGALS3; the disease is colorectal carcinoma.